Overview

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Dorzolamide
Maleic acid
Timolol